维普中文期刊产品整合服务
37篇 您的检索式:作者名="Bisping G"
    题名 作者 年代 出处 被引量
1Hyperfractionated Cyclophosphamide in Combination with Pulsed Dexamethasone and Thalidomide(HyperCDT) in Primary Refractory or Relapsed Multiple Myeloma显示文摘Kropff M H Lang N Bisping G 2003Br J Haematol2003,122,:1
2Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma 显示文摘Kropff M Bisping G Schuck E 2007Br J Haematol2007,138,3:1
3Proteasome inhibition in multiple myeloma 显示文摘Kropff M Bisping G Wenning D 2006Eur J Cancer2006,42,:1
4Hyperfractionated cyclophasphamide in combination with pulsed dexamethasone and thalidomide(HyperCDT)in primary refractory or relapsed multiple myelom显示文摘Kropff MH Lang N Bisping G etal 2003Br J Haematol2003,122,4:1
5Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor,plateletderived growth factor,and vascular endothelial growth factor receptors显示文摘Kulimova E Oelmann E Bisping G 0,,12:1
6Targeting receptor kinases by a novel indolinone derivative in multiple myeloma:abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups显示文摘Bisping G Kropff M Wenning D 0,,05:1
7Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts:evidence for a less activated protein kinase C in small adenomas显示文摘Assert R Kotter R Bisping G 1999Int J Cancer1999,80,1:1
8Proteasome Inhibition in Multiple Myeloma显示文摘Kropff M Bisping G Wenning D 2006Eur J Cancer2006,42,:1
9Bortezomib in combination with dexamethasone for relapsed multiple myeloma显示文摘Kropff MH Bisping G Wenning D 2005Leuk Res2005,29,5:1
10Bortezomib,dexamethasone,and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma显示文摘Bisping G Wenning D Kropff M 2009Clin Cancer Res2009,15,2:1
11Hyperfractionated cyclophos- phamide in combination with pulsed dexamethasone and thalidomide(HyperCDT) in primary refractory or relapsed multiple myeloma 显示文摘Kropff MH Lang N Bisping G 2003Br J Haematol2003,122,4:1
12Laparoscopic splenec- tomy for medically refractory immune thrombocytopenia (ITP) :a retrospective cohort study on longtime response predicting factors based on consensus criteria显示文摘Rijcken E Mees ST Bisping G et d 2014Int J Surg2014,12,12:1
13Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT)in primary refractory or relapsed multiple myeloma显示文摘Kropff MH Lang N Bisping G 2003Br J Haematol2003,,:1
14Proteasome inhibition in multiple myeloma显示文摘Kropff M Bisping G Wenning D 2006Eur J Cancer2006,42,11:1
15Colour Atlas for the diagnosis of bacteris pathogens in animals显示文摘Bisping W Amtsberg G 0,,:1
16Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide(HyperCDT)in primary refractory or relapsed multiple myeloma显示文摘Kropff M H Lang N Bisping G 2003Br J Haematol2003,122,:1
17Proteasome inhibition in multiple myeloma显示文摘Kropff M Bisping G Wenning D 2006Eur J Cancer2006,42,11:1
18Bortezomib in combination with dexamethasone for relapsed multiple myeloma显示文摘Kropff MH Bisping G Wenning D 2005Leuk Res2005,29,:1
19Bortezomib in combination with high-dose dexamethasome and continuous low-dose oral cyclophosphamide for relapsed muhiple myeloma 显示文摘Kropff M Bisping G Liebisch P 2005Blood2005,106,:1
20Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts: evidence for a less activated protein kinase C in small adenomas显示文摘Assert R Kotter R Bisping G 1999Int J Cancer1999,80,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费